These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23179231)

  • 1. Unilateral branch retinal arterial occlusion following administration of bevacizumab for branch retinal vein occlusion.
    Kaur S; Sachdev N
    Int Ophthalmol; 2013 Oct; 33(5):549-52. PubMed ID: 23179231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal bevacizumab for macular edema secondary to branch retinal vein occlusion.
    Ehlers JP; Decroos FC; Fekrat S
    Retina; 2011 Oct; 31(9):1856-62. PubMed ID: 21659943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bevacizumab for the treatment of macular edema secondary to retinal vein occlusion].
    Schaal KB; Höh AE; Scheuerle A; Schütt F; Dithmar S
    Ophthalmologe; 2007 Apr; 104(4):285-9. PubMed ID: 17372737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Off-label" use of intravitreal bevacizumab in non-ischemic macular edema secondary to retinal vein obstructions.
    Dascalu AM; Popa-Cherecheanu A; Popa-Cherecheanu M; Nica A; Serban D
    Rom J Ophthalmol; 2016; 60(2):90-95. PubMed ID: 29450329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined treatment of intravitreal bevacizumab and intravitreal triamcinolone in patients with retinal vein occlusion: 6 months of follow-up.
    Ehrlich R; Ciulla TA; Moss AM; Harris A
    Graefes Arch Clin Exp Ophthalmol; 2010 Mar; 248(3):375-80. PubMed ID: 19898827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macular infarction following intravitreal bevacizumab for treatment of central retinal vein occlusion.
    Leung LS; Silva RA; Blumenkranz MS; Flynn HW; Sanislo SR
    Ophthalmic Surg Lasers Imaging; 2012 Jul; 43 Online():e73-9. PubMed ID: 22823029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of the effect of intravitreal bevacizumab in branch retinal vein occlusion.
    Zhu D; Jin ZY; Tao Y; Jonas JB
    J Ocul Pharmacol Ther; 2013; 29(6):523-9. PubMed ID: 23537150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between intravitreal bevacizumab and triamcinolone for macular edema secondary to branch retinal vein occlusion.
    Kim JY; Park SP
    Korean J Ophthalmol; 2009 Dec; 23(4):259-65. PubMed ID: 20046685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion.
    Cheng KC; Wu WC; Chen KJ
    Eye (Lond); 2009 Nov; 23(11):2023-33. PubMed ID: 19798117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to branch retinal vein occlusions: results of the Pan American Collaborative Retina Study Group at 24 months.
    Wu L; Arevalo JF; Berrocal MH; Maia M; Roca JA; Morales-Cantón V; Alezzandrini AA; Díaz-Llopis MJ
    Retina; 2009; 29(10):1396-403. PubMed ID: 19898177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.
    Mayer WJ; Remy M; Wolf A; Kook D; Kampik A; Ulbig M; Reznicek L; Haritoglou C
    Ophthalmologica; 2012; 228(2):110-6. PubMed ID: 22739239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
    Mitry D; Bunce C; Charteris D
    Cochrane Database Syst Rev; 2013 Jan; (1):CD009510. PubMed ID: 23440840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomised, double-masked, controlled study of the efficacy and safety of intravitreal bevacizumab versus ranibizumab in the treatment of macular oedema due to branch retinal vein occlusion: MARVEL Report No. 1.
    Narayanan R; Panchal B; Das T; Chhablani J; Jalali S; Ali MH;
    Br J Ophthalmol; 2015 Jul; 99(7):954-9. PubMed ID: 25631483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in retinal blood flow in patients with macular edema secondary to branch retinal vein occlusion before and after intravitreal injection of bevacizumab.
    Nagaoka T; Sogawa K; Yoshida A
    Retina; 2014 Oct; 34(10):2037-43. PubMed ID: 24896136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectral domain OCT documented resolution of recalcitrant macular edema after intravitreal bevacizumab in branch retinal vein occlusion.
    Chalam KV; Keshavamurthy R; Brar VS
    Eur J Ophthalmol; 2008; 18(5):831-3. PubMed ID: 18850569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse events associated with intraocular injections of bevacizumab in eyes with neovascular glaucoma.
    Higashide T; Murotani E; Saito Y; Ohkubo S; Sugiyama K
    Graefes Arch Clin Exp Ophthalmol; 2012 Apr; 250(4):603-10. PubMed ID: 22116499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion.
    Jaissle GB; Szurman P; Feltgen N; Spitzer B; Pielen A; Rehak M; Spital G; Heimann H; Meyer CH;
    Graefes Arch Clin Exp Ophthalmol; 2011 Feb; 249(2):183-92. PubMed ID: 21337042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural Short-term Course of Recurrent Macular Edema Following Intravitreal Bevacizumab Therapy in Branch Retinal Vein Occlusion.
    Yoo SJ; Kim JH; Lee TG; Kim JW; Cho SW; Han JI
    Korean J Ophthalmol; 2017 Apr; 31(2):95-101. PubMed ID: 28367036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twelve-month safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES).
    Wu L; Martínez-Castellanos MA; Quiroz-Mercado H; Arevalo JF; Berrocal MH; Farah ME; Maia M; Roca JA; Rodriguez FJ;
    Graefes Arch Clin Exp Ophthalmol; 2008 Jan; 246(1):81-7. PubMed ID: 17674014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.